ADC Therapeutics SA ADCT 深 滬
等待開盤 11-26 09:30:00 美东时间
4.39
+0.020
+0.46%
華盛通- 最 高4.44
- 今 開4.39
- 成交量 52.52万股
- 最 低 4.21
- 昨 收 4.37
- 總市值 4.92亿
- 52周最高 4.80
- 市盈率 靜 --
- 換手率 0.00%
- 52周最低 1.05
- 委 比 52.67%
- 總股本 1.12亿
- 歷史最高 56.59
- 量 比 0.58
- 振 幅 5.26%
- 歷史最低 0.3599
- 每 手 1
- 風險率 1.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多ADC Therapeutics Q3 Adj. EPS $(0.19) Beats $(0.36) Estimate, Sales $16.427M Miss $17.077M Estimate
ADC Therapeutics (NYSE:ADCT) reported quarterly losses of $(0.19) per share which beat the analyst consensus estimate of $(0.36) by 47.51 percent. This is a 32.14 percent increase over losses of $(0.28) per share from
11-10 20:32
Earnings Scheduled For November 10, 2025
Companies Reporting Before The Bell • CBAK Energy Tech (NASDAQ:CBAT) is likely ...
11-10 19:12
Earnings Preview For ADC Therapeutics
ADC Therapeutics (NYSE:ADCT) is gearing up to announce its quarterly earnings o...
11-08 01:04
ADC Therapeutics to Present at November Investor Conferences
LAUSANNE, Switzerland, Oct. 27, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ann...
10-27 19:15
美股大行评级 | Needham上调台积电目标价升至360美元！美国银行、摩根士丹利分别获多家机构上调目标价
今日重点评级关注：Rosenblatt：维持HIVE Digital Technologies"买入"评级，目标价从5美元升至10美元；摩根大通：维持Array Technologies"超配"评级，目标价从13美元升至15美元
10-17 09:58
HC Wainwright & Co. Maintains Buy on ADC Therapeutics, Lowers Price Target to $7
HC Wainwright & Co. analyst Robert Burns maintains ADC Therapeutics (NYSE:ADCT) with a Buy and lowers the price target from $8 to $7.
10-16 19:24
ADC Therapeutics rises on $60M PIPE financing
ADC Therapeutics (NYSE:ADCT) has entered into securities purchase agreements with certain institutional investors for a $60.0 million private investment in public equity (PIPE) financing. Under the PI...
10-13 19:50
ADC Therapeutics Announces $60 Million Private Placement
LAUSANNE, Switzerland, Oct. 13, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today ann...
10-13 19:30
ADC Therapeutics Makes Grants to New Employees Under Inducement Plan
LAUSANNE, Switzerland, Oct. 1, 2025 /PRNewswire/ -- ADC Therapeutics SA (NYSE: ADCT), a commercial-stage global leader and pioneer in the field of antibody drug conjugates (ADCs), today anno...
10-02 04:05
ADC Therapeutics Updates Strategic Focus on ZYNLONTA
ADC Therapeutics ( ($ADCT) ) just unveiled an announcement. On September 30, 20...
09-30 21:50
